Search for: [Abstract = ", David Goldberg's GHQ\-28 Questionnaire, and the four\-dimensional 4DSQ Questionnaire were used to analyze the occurrence of anxiety, depression, and somatization symptoms. The list of common side effects of treatment with interferon\-alpha and IKT was created based on the results of research analyzing their effects and toxicity. Results\: The research has shown that every third person suffering from MPN and CML is at risk of developing mental disorders. In addition, a moderately and strongly increased result was obtained in both groups\: on the scale of depressive symptoms from 20% to almost 40% of respondents, on the scale of anxiety symptoms from 20% to less than 50% of patients, and on the scale of somatization symptoms from over 35% to over 70% of respondents. Somatization symptoms had the most significant impact on the occurrence of mental disorders, then anxiety and insomnia. In both groups, age, as well as the number of experienced side effects significantly influenced the intensity of depression, anxiety, and somatization symptoms. The results of the studies showed that age, number of side effects, and female gender were predictors of the occurrence of somatization and anxiety symptoms in the group of patients with CML. In the same group, age \(B = 0.082\; p = 0.008\) and the number of side effects \(B = 0.726\; p = 0.000\) were factors increasing"]
